The role of dietary nucleotides in neonatal and infant nutrition.
Human milk has a higher concentration of nucleotides than bovine milk which is the source of most infant formulas. As the composition of human milk is considered the 'gold standard,' an increasing number of infant formulas are supplemented with nucleotides. This review summarises the biology of human milk nucleotides and evaluates the studies which investigated the clinical benefits of feeding infants with nucleotide-supplemented formulas. Although dietary nucleotides have been suggested to have beneficial gastrointestinal and immunological effects, nucleotide-supplemented formula feeding has not been shown to confer the same benefits as breast feeding, and randomised controlled trials have yet to prove that healthy term infants fed nucleotide-supplemented formulas compared to those fed nonsupplemented formulas, have accelerated physical growth and neurological development, better growth and development of their gastrointestinal tract resulting in improved digestive and absorptive functions, enhanced development of their immune system resulting in increased resistance to infection and lower bacterial and viral infection rates during infancy, and a more favourable intestinal microflora associated with a lower rate of infectious diarrhoea. However, a randomised controlled trial has reported that term infants with severe intrauterine growth retardation do have better catch-up growth with nucleotide supplementation. The hypothesis that nucleotides are semi-essential nutrients needs to be further studied, in particular in the presence of prematurity, fetal growth retardation, intestinal injury and limited nutrient intake. As no deleterious effects have been reported with the use of nucleotide-supplemented formulas, the first of which was introduced over 30 years ago, such products are considered safe when nucleotides are supplemented to an amount equivalent to the free nucleotide concentration of human milk. More basic and clinical research studies are awaited to further define the biology and role of human milk nucleotides, and to critically assess the potential benefits and appropriate level of nucleotide supplementation of infant formula.
Neonatal Intensive Care Unit, Monash Medical Centre, Clayton, Victoria, Australia.
V Y
VY
Yu
D000818:Animals; D001942:Breast Feeding; D002417:Cattle; D002490:Central Nervous System / Q000254:growth & development; D004040:Dietary Carbohydrates / Q000008:administration & dosage / Q000032:analysis; D004064:Digestive System / Q000254:growth & development; D005317:Fetal Growth Retardation / Q000503:physiopathology; D005527:Food, Fortified; D006128:Growth; D006801:Humans; D007109:Immunity; D007225:Infant Food / Q000032:analysis; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007234:Infant, Premature; D008892:Milk / Q000737:chemistry; D008895:Milk, Human / Q000737:chemistry; D009711:Nucleotides / Q000008:administration & dosage* / Q000032:analysis; D016032:Randomized Controlled Trials as Topic
D004040:Dietary Carbohydrates; D009711:Nucleotides